Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter-Reference-Cited by-同舟云学术

Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter

Published:2008-01-03 Issue:4-6 Volume:377 Page:597-605
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmied Arch Pharmacol

Author:

Sugatani Junko,Mizushima Kousuke,Osabe Makoto,Yamakawa Kasumi,Kakizaki Satoru,Takagi Hitoshi,Mori Masatomo,Ikari Akira,Miwa Masao

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-007-0226-y.pdf

Reference38 articles.

1. Akiyama TE, Ward JM, Gonzalez FJ (2000) Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alteration in fatty acid homeostasis in HNF1alpha-deficient mice. J Biol Chem 275:27117–27122

2. Aono S, Yamada Y, Keino H, Sasaoka Y, Nakagawa T, Onishi S, Mimura S, Koiwai O, Sato H (1994) A new type of defect in the gene for bilirubin uridine 5′-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I. Pediatr Res 35:629–632

3. Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H (1995) Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert’s syndrome. Lancet 345:958–959

4. Arabi Y, Morgan BJ, Goodman B, Puleo DS, Xie A, Skatrud JB (1999) Daytime blood pressure elevation after nocturnal hypoxia. J Appl Physiol 87:689–698

5. Auyeung DJ, Kessler FK, Ritter JK (2003) Differential regulation of alternate UDP-glucuronosyltransferase 1A6 gene promoters by hepatic nuclear factor-1. Toxicol Appl Pharmacol 191:156–166

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Natural Compounds Modulating Heme Catabolic Pathway in Gut, Liver, Cardiovascular, and Brain Diseases;Biomolecules;2024-01-02

2. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

3. The physiology of bilirubin: health and disease equilibrium;Trends in Molecular Medicine;2023-04

4. Biliverdin and Bilirubin as Parallel Products of CO Formation;Carbon Monoxide in Drug Discovery;2022-05-07

5. PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1;Cancers;2021-07-20